Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab

Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab

Vaccination can prevent infection and disease due to SARS-CoV-2. Early reports indicate that immune suppressed or immune compromised populations have reduced immune responses to US emergency use authorized (EUA) vaccines. Patients with autoimmune disorders are at risk for severe COVID-19, and are fr...

Full description

Bibliographic Details
Main Authors: Lisa C. Plymate, MD, Gregory Pepper, Maxwell P. Krist, David M. Koelle, MD
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Journal of Translational Autoimmunity
Subjects:
Mycophenolate sodium
Corticosteroid
SARS-CoV-2
Vaccine
Eculizumab
Myasthenia gravis
Online Access:http://www.sciencedirect.com/science/article/pii/S2589909021000344

Internet

http://www.sciencedirect.com/science/article/pii/S2589909021000344

Similar Items